1. Market Research
  2. > Healthcare Market Trends
Asia-Pacific Regulations Driving Innovation in Healthcare 

Asia-Pacific Regulations Driving Innovation in Healthcare 

  • October 2015
  • 11 pages
  • ID: 3358473
  • Format: PDF
  • By Frost & Sullivan


Table of Contents

About this Study

Innovation is fundamental to the growth of the healthcare market In recent years, many governments in the Asia-Pacific (APAC) region have rolled out favorable regulations to encourage innovation in the healthcare industry This article examines two types of government regulations that can promote innovation in healthcare First, Frost & Sullivan discusses government initiatives in driving the growth of healthcare research and development (R&D) by highlighting those adopted in China, South Korea, Taiwan, and Singapore

These countries showcased the highest increase in R&D investments between 2009 and 2012 Second, by focusing on the Association of Southeast Asian Nations (ASEAN), we look at policies that aim to enhance the delivery of and access to healthcare products and services Findings presented in this article are supported by a deeper analysis in the research “Impact of Policies Shaping ASEAN1 Healthcare – Outlook till 2020”

Policies Driving Increasing R&D Expenditure in APAC

Innovation in any industry, let alone healthcare, is improbable without investments in R&D A minimum threshold of R&D is expected to drive healthy innovation across companies, countries, and regions Not only does R&D investment fuel the development and growth of new products and technologies, it also sparks curiosity and enthusiasm, essential characteristics for a progressive and productive workforce R&D expenditure is considered to be an essential criterion that reflects national development It is influenced by a number of factors including political climate, fiscal policies, resource availability, and regulatory regimes

Globally, there has been a decline in R&D spending, including in the healthcare industry Even though healthcare has been more resilient on this front compared with other industries, this trend is expected to reverse with the growing need for improvements in cost and quality of care across almost all countries and regions over the next few years Between 2007 and 2012, the total investment in healthcare R&D increased at a compound annual growth rate (CAGR) of only %

The significant drop in global healthcare R&D spending in 2009 was a result of the Recession as well as cuts in healthcare expenditure across developed markets as part of austerity measures

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 150+ Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
  • Single User License — provides access to the report by one individual.
  • Department License — allows you to share the report with up to 5 users
  • Site License — allows the report to be shared amongst all employees in a defined country
  • Corporate License — allows for complete access, globally.
Ahmad helps you find the right report:

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

We were impressed with the support that ReportLinker’s research specialists’ team provided. The report we purchased was useful and provided exactly what we want.

Category Manager at

ReportLinker gave access to reliable and useful data while avoiding dispersing resources and spending too much time on unnecessary research.

Executive Director at
PwC Advisory

The customer service was fast, responsive, and 100% professional in all my dealings (...) If we have more research needs, I'll certainly prioritize working with ReportLinker!

Scott Griffith

Vice President Marketing at
Maurice Sporting Goods

The research specialist provided prompt, helpful instructions for accessing ReportLinker's product. He also followed up to make sure everything went smoothly and to ensure an easy transition to the next stage of my research

Jessica P Huffman

Research Associate at
American Transportation Research Institute

Excellent customer service. Very responsive and fast.

Director, Corporate Strategy at

I reached out to ReportLinker for a detailed market study on the Air Treatment industry. The quality of the report, the research specialist’s willingness to solve my queries exceeded my expectations. I would definitely recommend ReportLinker for in-depth industry information.

Mariana Mendoza

Global Platform Senior Manager at
Whirlpool Corporation

Thanks! I like what you've provided and will certainly come back if I need to do further research works.

Bee Hin Png

CEO at
LDR Pte Ltd

The research specialist advised us on the best content for our needs and provided a great report and follow-up, thanks very much we shall look at ReportLinker in the future.

Kate Merrick

Global Marketing Manager at
Eurotherm by Schneider Electric

  • How we can help
    • I am not sure if the report I am interested in will fulfill my needs. Can you help me?
    • Yes, of course. You can call us at +33(0) 4 37 65 17 03 or drop us an email at researchadvisor@reportlinker.com to let us know more about your requirements.
    • We buy reports often - can ReportLinker get me any benefits?
    • Yes. Set up a call with a Senior Research Advisor to learn more - researchadvisor@reportlinker.com or +33(0) 4 37 65 17 03.
    • I have had negative experiences with market research reports before. How can you avoid this from happening again?
    • We advise all clients to read the TOC and Summary and list your questions so that we can get more insight for you before you make any purchase decision. A research advisor will accompany you so that you can compare samples and reports from different sources, and choose the study that is right for you.

  • Report Delivery
    • How and when I will receive my Report?
    • Most reports are delivered right away in a pdf format, while others are accessed via a secure link and access codes. Do note that sometimes reports are sent within a 12 hour period, depending on the time zones. However, you can contact us to escalate this. Should you need a hard copy, you can check if this option is offered for the particular report, and pay the related fees.
  • Payment conditions
    • What payment methods do you accept?
      1. Credit card : VISA, American Express, Mastercard, or
      2. You can download an invoice to pay by wire transfer, check, or via a Purchase Order from your company, or
      3. You can pay via a Check made out in US Dollars, Euros, or British Pounds for the full amount made payable to ReportLinker
    • What are ReportLinker’s Payment Terms?
    • All payments must normally be submitted within 30 days. However, you can let us know if you need extended time.
    • Are Taxes and duties included?
    • All companies based in France must pay a 20% tax per report. The same applies to all individuals based in the EU. All EU companies must supply their VAT number when purchasing to avoid this charge.
    • I’m not satisfied. Can I be refunded?
    • No. Once your order has been processed and the publisher has received a notification to send you the report, we cannot issue any refund or cancel any order. As these are not ‘traditional’ products that can be returned, reports that are dispatched are considered to be ‘consumed’.
  • User license
    • The license that you should acquire depends on the number of persons that need to access the report. This can range from Single User (only one person will have the right to read or access the report), or Department License (up to 5 persons), to Site License (a group of persons based in the same company location), or Corporate License (the entire company personnel based worldwide). However, as publishers have different terms and conditions, we can look into this for you.
Purchase Reports From Reputable Market Research Publishers
Arterial Thrombosis - Pipeline Review, H2 2019

Arterial Thrombosis - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Arterial Thrombosis - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Arterial Thrombosis - Pipeline Review, H2 2019, provides an overview of the Arterial ...



  • $ 2500
  • October 2019

KEY FINDINGSThe global blood plasma market is approximated to project a CAGR of 6.04% during the forecast period. The increasing transplantations across the globe, the increasing use of albumin, and the ...

Tetanus - Pipeline Review, H2 2019

Tetanus - Pipeline Review, H2 2019

  • $ 2000
  • November 2019

Tetanus - Pipeline Review, H2 2019SummaryThe latest Pharmaceutical and Healthcare disease pipeline guide Tetanus - Pipeline Review, H2 2019, provides an overview of the Tetanus (Infectious Disease) pipeline ...


Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on